Jaewon Oh
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Cardiovascular Function and Risk Factors 24
- Heart Failure Treatment and Management 19
- Blood Pressure and Hypertension Studies 13
- Cardiomyopathy and Myosin Studies 12
- Cardiac pacing and defibrillation studies 12
- Co-authors
- Seok‐Min KangSungha ParkKwang Pyo KimSang‐Hak LeeChan Joo LeeYangsoo JangRaju BanduDonghoon Choi
- Journals
- Scientific Reports (9 papers)Stem Cell Research (6 papers)PLoS ONE (6 papers)Journal of Cardiac Failure (5 papers)Journal of Hypertension (5 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Jaewon Oh
164 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 131
- Cardiology and Cardiovascular Medicine 727
- Cancer Research 218
- Endocrinology, Diabetes and Metabolism 220
- Ophthalmology 95
- Molecular Biology 590
Countries citing papers authored by Jaewon Oh
This map shows the geographic impact of Jaewon Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaewon Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaewon Oh more than expected).
Fields of papers citing papers by Jaewon Oh
This network shows the impact of papers produced by Jaewon Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaewon Oh. The network helps show where Jaewon Oh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jaewon Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 10 | |
| 15 | 2022 | 1 | |
| 16 | 2021 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2020 | 11 | |
| 19 | Adiponectin & inflammatory biomarkers in coronary artery disease | 2014 | 1 |
| 20 | 2014 | 6 |
About Jaewon Oh
Jaewon Oh is a scholar working on Cardiology and Cardiovascular Medicine, Transplantation, Surgery, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging, having authored 177 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (24 papers), Heart Failure Treatment and Management (19 papers), Lipoproteins and Cardiovascular Health (16 papers), Blood Pressure and Hypertension Studies (13 papers), Cardiomyopathy and Myosin Studies (12 papers), Cardiac pacing and defibrillation studies (12 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Cardiac Imaging and Diagnostics (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (727 citations), Cancer Research (218 citations), Endocrinology, Diabetes and Metabolism (220 citations), Ophthalmology (95 citations) and Molecular Biology (590 citations). Jaewon Oh has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Seok‐Min Kang, Sungha Park, Kwang Pyo Kim, Sang‐Hak Lee, Chan Joo Lee, Yangsoo Jang, Raju Bandu, Donghoon Choi, Ji Hyung Chung and Beom Seob Lee. Their work appears in journals such as Scientific Reports, Stem Cell Research, PLoS ONE, Journal of Cardiac Failure and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.